Head and Neck Cancer [clinicaltrials_resource:70d680c8c823bfde720d47581d386762]
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00002476]Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx [clinicaltrials:NCT00002496]Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer [clinicaltrials:NCT00002506]Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer [clinicaltrials:NCT00002507]Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer [clinicaltrials:NCT00002515]Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer [clinicaltrials:NCT00002520]Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer [clinicaltrials:NCT00002533]High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer [clinicaltrials:NCT00002555]Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors [clinicaltrials:NCT00002608]Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer [clinicaltrials:NCT00002632]Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00002654]Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer [clinicaltrials:NCT00002659]clinicaltrials:NCT00002670Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck [clinicaltrials:NCT00002695]Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx [clinicaltrials:NCT00002702]Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord [clinicaltrials:NCT00002727]clinicaltrials:NCT00002735Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer [clinicaltrials:NCT00002747]Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx [clinicaltrials:NCT00002839]Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00002888]Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function [clinicaltrials:NCT00002901]Paclitaxel in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00002922]Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck [clinicaltrials:NCT00002932]Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer [clinicaltrials:NCT00002947]clinicaltrials:NCT00002951Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer [clinicaltrials:NCT00002964]S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx [clinicaltrials:NCT00002999]clinicaltrials:NCT00003040Chemotherapy in Treating Patients With Solid Tumors [clinicaltrials:NCT00003103]clinicaltrials:NCT00003139Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck [clinicaltrials:NCT00003182]clinicaltrials:NCT00003193Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck [clinicaltrials:NCT00003200]Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer [clinicaltrials:NCT00003206]clinicaltrials:NCT00003223Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer [clinicaltrials:NCT00003251]Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer [clinicaltrials:NCT00003257]Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer [clinicaltrials:NCT00003264]Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer [clinicaltrials:NCT00003327]Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [clinicaltrials:NCT00003328]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT02073032 [clinicaltrials_resource:71f1b1cfd67a0fcda4acb6e1bed6af01]eligibility for clinicaltrials:NCT00120211 [clinicaltrials_resource:739565db38584f6329634a419f7af36a]eligibility for clinicaltrials:NCT01949974 [clinicaltrials_resource:b235b1ec7860683089ef46825762a953]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT02073032 [clinicaltrials_resource:71f1b1cfd67a0fcda4acb6e1bed6af01]eligibility for clinicaltrials:NCT00120211 [clinicaltrials_resource:739565db38584f6329634a419f7af36a]eligibility for clinicaltrials:NCT01949974 [clinicaltrials_resource:b235b1ec7860683089ef46825762a953]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Head and Neck Cancer [clinicaltrials_resource:70d680c8c823bfde720d47581d386762]
Bio2RDF identifier
70d680c8c823bfde720d47581d386762
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:70d680c8c823bfde720d47581d386762
identifier
clinicaltrials_resource:70d680c8c823bfde720d47581d386762
title
Head and Neck Cancer
@en
label
Head and Neck Cancer [clinicaltrials_resource:70d680c8c823bfde720d47581d386762]
@en